Oxford BioMedica plc (OXB.L)
LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
As of 03:03PM GMT. Market open.
| Previous close | 452.50 |
| Open | 451.96 |
| Bid | 449.50 x 0 |
| Ask | 453.50 x 0 |
| Day's range | 444.98 - 457.50 |
| 52-week range | 276.62 - 870.00 |
| Volume | |
| Avg. volume | 127,697 |
| Market cap | 435.777M |
| Beta (5Y monthly) | 1.03 |
| PE ratio (TTM) | 22.47 |
| EPS (TTM) | 0.20 |
| Earnings date | 18 Apr 2023 - 24 Apr 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 1,070.29 |
- Simply Wall St.
The past year for Oxford Biomedica (LON:OXB) investors has not been profitable
Oxford Biomedica plc ( LON:OXB ) shareholders should be happy to see the share price up 26% in the last quarter. But...
- Simply Wall St.
A Look At The Intrinsic Value Of Oxford Biomedica plc (LON:OXB)
How far off is Oxford Biomedica plc ( LON:OXB ) from its intrinsic value? Using the most recent financial data, we'll...
- Globe Newswire
Oxford Biomedica Appoints Dr Frank Mathias as Chief Executive Officer
The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 (as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018). Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain. Oxford Biomedica Appoints Dr Frank Mathias as Chief Executive Officer Oxford, UK – 22
© 2023 Yahoo. All rights reserved.
